speb/financial-data huggingface dataset:
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 4778129000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 4410313000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 367816000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 575417000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -4306338000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -472776000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1483728000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -5687425000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 4432173000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 672116000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 8120840000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 1600000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 664653000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 9967055000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 9594647000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 119000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 178262000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 178381000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 4329726000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 22545000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Deferred Tax: -625000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 804098000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 804098000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 804097000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 804097000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 59086860.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 91.18
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — EBIT: 6960164000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 7764262000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -4474000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 4771873000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 320000000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 6573541000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 188622000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 0.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -2599940000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -434707000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 276083000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 584577000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 105217000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3658194000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5291352000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 7124444000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 175693000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 977955000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 977955000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 100493000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 100493000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -1894765000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 208729000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 745492000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 10286521000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -271532000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 22991000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1100279000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 17777000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 1600000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 7251078000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 59697000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 2195000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1987419000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1989614000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 7251078000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -7417398000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 17777000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 98862000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 2908321000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Minority Interest: -171000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 1600000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -24979000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 5387502000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 2072227000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 5387502000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: -937257000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 148272000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -166320000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -166320000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -937257000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 8633026000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 1000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2308628000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -628533000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 8015623000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 65469000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 512116000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 12264000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 207246000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 3447987000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 1496783714.74
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -1869836000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Operating Income: 2424540000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 17091499000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 59086860.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 565009000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: -2000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 105217000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 1000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 869779000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -3000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -2000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 15149000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 363102000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 58705000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 244930000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 15229000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: -3881568000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 2996672000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 8045000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 443937000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 5982209000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 247668000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -730104000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 507145000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 9967055000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 804098000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 17090000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 17090000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -7417398000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 160000000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -3880327000.00
INDSWFTLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 101571000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 723323000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1307900000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 59086860.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: 3881568000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 8120840000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 8015623000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 425556714.74
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 589807000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.10
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 322135000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 14604338000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 10108259000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2167995000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 8120669000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 14666959000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 6483669000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 5009691000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 2153943000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 59795000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 9003000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 4316275000.00
INDSWFTLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 4316275000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 49724000.00
INDSWFTLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 5264921000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — +Operating Expense: 727779000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — +Total Revenue: 1483020000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 412415000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 575481000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1923607000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 67543284.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.67
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 590869000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4384552000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 4384552000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 590869000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 10115456000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Cost Of Revenue: 781981000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 5867959000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 54940000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 54940000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1643714000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 1019508000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Depreciation And Amortization In Income Statement: 56110000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Depreciation Income Statement: 56110000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 67543284.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.67
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Diluted NI Availto Com Stockholders: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — EBIT: 146325000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — EBITDA: 202435000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 50193000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Gross Profit: 701039000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Interest Expense: 99369000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 99369000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 93289000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 10279417000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Investment Properties: 22761000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1923607000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 109021000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 109021000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Equity Investment: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 12264000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: -257000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Common Stockholders: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Continuous Operations: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Income Including Noncontrolling Interests: 45254000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Interest Income: -99369000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: -99369000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 50193000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 10115456000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 318484000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Normalized EBITDA: 201546000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Normalized Income: 44399930.68
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Operating Income: -26740000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Operating Revenue: 1483020000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 59086860.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 814637000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 156851000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 9524587000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 3697194000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 172176000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Other Operating Expenses: 383229000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 50193000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Other Special Charges: -889000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Otherunder Preferred Stock Dividend: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 412415000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Pretax Income: 46956000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Properties: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Reconciled Cost Of Revenue: 781981000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Reconciled Depreciation: 56110000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 59086860.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 889000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 10115456000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 10115456000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Tax Effect Of Unusual Items: 34930.68
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Tax Provision: 1845000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Tax Rate For Calcs: 0.04
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 11880198000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 10224477000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 163961000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 10115199000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Total Expenses: 1509760000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1764999000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 6012239000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 121285000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 889000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 889000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 4224245000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 795881000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 1287986000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 66978049.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Basic EPS: -0.82
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 616724000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 58122000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 58122000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 66978049.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.82
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — EBIT: 34479000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — EBITDA: 92601000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 671262000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 100276000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 100276000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -54922000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -100276000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -100276000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 99858000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Normalized Income: -48851650.80
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Operating Income: -124619000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 1287986000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 166355000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 441137000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Pretax Income: -65797000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 616724000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 58122000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: -7257000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -1186650.80
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Tax Provision: -10759000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.16
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1412605000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -7257000.00
INDSWFTLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -7257000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 3176292000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 971630000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 5742392000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1423659000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1102337000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1102337000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1645193000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1645193000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3080859000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3080859000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 3996455000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 3996455000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -525850000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -525850000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 1227987000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 1227987000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Average Dilution Earnings: 0.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 67260070.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 67272639.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 37.24
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 33.04
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 4939294000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1365287000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1365287000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -644061000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 2425000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2425000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 687436000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 687436000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4120383000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4120383000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4514043000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4514043000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 3876114000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 3876114000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 244269000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 244269000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -431578000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -63935000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -670484000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 968439000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -197558000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -693941000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 687436000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 687436000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 11729997000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11729997000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 926341000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 201478000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 201478000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 2879521000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 570641000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 8653463000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 8653463000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 154000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 154000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 149061000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 149061000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 149215000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 149215000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2205802000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2205802000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 18284000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 18284000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Deferred Tax: -33493000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 244793000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 244793000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 244793000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 74373000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 244793000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 74373000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 71137887.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 71148784.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 35.21
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 31.24
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — EBIT: 2607178000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: -118612000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 2851971000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: -44239000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 5776000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 4251128000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 320000000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 320000000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 724214000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 206336000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 206336000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 0.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -930964000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -287222000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 496688000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 106813000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 106813000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2171043000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2171043000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 5737599000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 5737599000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 2862871000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 853018000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Held To Maturity Securities: 175693000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 175693000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 29193000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 6889000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 29193000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 6889000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 382687000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Interest Income: 267572000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 382687000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 267572000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -419080000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 385147000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 1141764000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1141764000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 12136136000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12136136000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1131252000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 22532000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 22532000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1723680000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1723680000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 17259000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 17259000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 926341000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 275972000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 263824000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 263824000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 2271000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2271000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 257078000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 257078000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 259349000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 259349000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 275972000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -66043000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 17259000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 17259000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 113670000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 113670000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 3636783000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3636783000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Minority Interest: -348000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: -348000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 926341000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 2222688000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 345943000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 2504765000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 2222688000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: -29193000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: 267572000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -1258302000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 209929000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 209929000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -29193000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 267572000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 7024000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2656740000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2656740000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -258097000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 11623184000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 11623184000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 74915000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 74915000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 446411000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 446411000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 21045000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 21045000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 619929000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -2203035000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 335668162.77
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 140612117.84
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: -286903000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Operating Income: -313421000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: -118612000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 5742392000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1423659000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 60618860.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 60618860.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 1050073000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1050073000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 40565000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 40565000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 740968000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 740968000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 106813000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 106813000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Inventories: -1000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: -1000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -361903000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 3000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: 1000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 688557000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -3121000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1756289000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 584047000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 603997000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 603997000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 270227000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 270227000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 220685000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 220685000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 393660000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 393660000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Other Special Charges: -2519265000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 1748427000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1748427000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 18000000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 593902000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 593902000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 2577985000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 2304635000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 16705000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -644061000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 832918000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 832918000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2879521000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 570641000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 244793000.00
INDSWFTLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 74373000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 16354000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 16354000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -66043000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 160000000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 160000000.00
INDSWFTLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -1375385000.00
INDSWFTLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1375385000.00
INDSWFTLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 385964000.00
INDSWFTLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 642031000.00